Physician profile
Divya Chari
NPI 1750700415
$11,126.54
in general payments reported to CMS, 2019-2025
9 companies · $2,233 in 2025
The $2,233 reported for 2025 was more than what 90% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,605 · 2022: $1,601 · 2023: $1,700 · 2024: $2,987 · 2025: $2,233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,651 · Food and Beverage: $2,269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,650.60 |
| Food and Beverage | $2,269.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $7,450.91 | 2019-2025 | Core, N/A |
| Medical Device Business Services, INC. | $1,091.74 | 2019 | |
| Med-El Corporation | $1,028.79 | 2024 | |
| Cochlear Americas | $835.15 | 2019-2025 | Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant |
| Advanced Bionics, LLC | $349.35 | 2022-2025 | Hires Ultra Ci Hifocus Ms Electrode |
| Intersect Ent, INC. | $180.15 | 2019 | |
| Iotamotion, INC. | $82.31 | 2025 | Iotasoft |
| 3-D Matrix, INC. | $72.57 | 2024 | |
| Inspire Medical Systems, INC. | $35.57 | 2024 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Divya Chari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.